Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine

Journal of Medical Virology

Volumn 84, Issue 1, 2012, Pages 11-17

  Van Damme, P ^a   Leroux Roels, G ^b   Crasta, P ^c   Messier, M ^d   Jacquet, J M ^d   Van Herck, K ^a,e  

^a Vaccine and Infectious Disease Institute   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GlaxoSmithKline Pharmaceuticals Ltd   (India)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

Combined; Hepatitis; Immune memory; Persistence; Three dose; Vaccine

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; DRUG SAFETY; FOLLOW UP; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; MULTIPLE CYCLE TREATMENT; OPEN STUDY; UNSPECIFIED SIDE EFFECT; VACCINATION;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS B ANTIBODIES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; TIME FACTORS; VACCINATION; YOUNG ADULT;

HEPATITIS A VIRUS;

EID: 81355161156     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22264     Document Type: Article

References (31)

1. Andersson KL, Friedman LS. 2010. Hepatitis A: A travelling target. Arch Intern Med 20:1818-1819.
2. Andre FE. 2006. Universal mass vaccination against hepatitis A. Curr Top Microbiol Immunol 304:95-114.
3. Askling HH, Rombo L, Andersson Y, Martin S, Ekdahl K. 2009. Hepatitis A risk in travelers. J Travel Med 16:233-238. DOI: 10.1111/j.1708-8305.2009.00307.x.
4. Banatvala J, Van Damme P, Oehen S. 2000. Lifelong protection against hepatitis B: The role of vaccine immunogenicity in immune memory. Vaccine 19:877-885.
5. Beran J, Kervyn D, Wertzova V, Hobzova L, Tichy P, Kuriyakose S, Leyssen M, Jacquet JM. 2010. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents. Vaccine 28:5993-5997. Epub 2010.
6. Bruguera M, Bayas JM, Vilella A, Tural C, González A, Vidal J, Dal-Ré R, Sallaras L. 1996. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. Vaccine 15:1407-1411.
7. Burgess M, Rodger A. 2001. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine Twinrix™ in healthy adolescent volunteers an open randomised study. Vaccine 19:4835-4841.
8. Burgess MA, McIntyre PB, Hellard M, Ruff TA, Lefevre I, Bock HL. 2010. Antibody persistence six years after two doses of combined hepatitis A and B vaccine. Vaccine 28:2222-2226.
9. Cambron P, Jacquet JM, Hoet B, Lievens M. 2009. Development, technical and clinical validation of a quantitative 2 ELISA for the detection of human antibodies to Hepatitis B surface 3 antigen (HBsAg) in recipients of recombinant HBV vaccine. Clin Vaccine Immunol 16:1236-1246.
10. Chatproedprai S, Chongsrisawat V, Chatchatee P, Theamboonlers A, Yoocharoen P, Warinsathien P, Tharmaphornpilas P, Warintrawat S, Sinlaparatsamee S, Chaiear K, Khwanjaipanich S, Paupunwatana S, Poovorawan Y. 2007. Declining trend in the seroprevalence of infection with hepatitis A virus in Thailand. Ann Trop Med Parasitol 101:61-68.
11. Duval B, Gîlca V, Boulianne N, De Wals P, Massé R, Trudeau G, De Serres G. 2005. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country. Pediatr Infect Dis J 24:213-218.
12. Feinstone SM, Gust ID. 1999. Hepatitis A vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines, 3rd edition. Philadelphia, PA: WB Saunders. pp 650-671.
13. Gabbuti A, Romano L, Blanc P, Meacci F, Amendola A, Mele A, Mazzotta F, Zanetti R. 2007. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine 25:3129-3132.
14. Jacobsen KH. 2009. The global prevalence of hepatitis A virus infection and susceptibility: A systematic review. Geneva, Switzerland: World Health Organization.
15. Jacobsen KH, Wiersma ST. 2010. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 28:6653-6657.
16. Lee SD, Chan CY, Yu MI, Wang YJ, Chang FY, Lo KJ, Safary A. 1999. A two dose combined hepatitis A and B vaccine in Chinese youngsters. J Med Virol 59:1-4.
17. Leroux-Roels G, Moreau E, Desombere I, Safary A. 1996. Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults. Scand J Gastroenterol 3:1027-1031.
18. Mahoney FJ, Kane M. 1999. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines, 3rd edition. Philadelphia, PA: WB Saunders. pp 158-182.
19. Murdoch DL, Goa K, Figgitt DP. 2003. Combined hepatitis A and B vaccines: A review of their immunogenicity and tolerability. Drugs 63:2625-2649.
20. Rendi-Wagner P, Korinek M, Winkler B, Kundi M, Kollaritsch H, Wiedermann U. 2007. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine 25:927-931.
21. Thoelen S, Van Damme P, Leentvaar-Kuypers A, Leroux-Roels G, Bruguera M, Frei PC, Bakasenas V, Safary A. 1999. The first combined vaccine against hepatitis A and B: An overview. Vaccine 17:1657-1662.
22. Torner N, Broner S, Martinez A, Godoy P, Batalla J, Dominguez A, Hepatitis A Surveillance Group of Catalonia. 2011. Hepatitis A outbreaks: The effect of a mass vaccination programme. J Viral Hepat 18:e1-e4.
23. Van Damme P, Leroux-Roels G, Law B, Diaz-Mitoma F, Desombere I, Collard F, Tornieporth N, Van Herck K. 2001. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. J Med Virol 65:6-13.
24. Van Damme P, Banatvala J, Fay O, Iwarson S, McMahon B, Van Herck K, Shouval D, Bonanni P, Connor B, Cooksley G, Leroux-Roels G, Von Sonnenburg F. 2003. Hepatitis A booster vaccination: Is there a need? Lancet 362:1065-1071.
25. Van Der Wielen M, Van Damme P, Collard F. 2000. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years. Pediatr Infect Dis J 9:848-853.
26. Van Herck K, Van Damme P, Collard F, Thoelen S. 1999. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years. Scand J Gastroenterol 34:1236-1240.
27. Van Herck K, Leroux-Roels G, Van Damme P, Srinivasa K, Hoet B. 2007. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix™) in adults. Travel Med Infect Dis 5:171-175.
28. WHO. 2000. Hepatitis A position paper. Wkly Epidemiol Rec 75:38-44.
29. WHO. 2008. Hepatitis A fact sheet. No. 328, May 2008. Available: [Accessed on 1 July 2011].
30. WHO. 2009. Hepatitis B position paper. Wkly Epidemiol Rec 84:405-420.
31. Zuckerman JN, Hoet B. 2008. Hepatitis B immunisation in travellers: Poor risk perception and inadequate protection. Travel Med Infect Dis 6:315-320.